Rita King, CEO of MethodSense, provides her expertise on the integration of AI in medical devices and key developments for pharmacists as the technology evolves.

At 48 weeks, participants receiving the highest dose combination of 9 mg eloralintide and 15 mg tirzepatide achieved an ...

Pharmacists are moving well beyond the dispensing counter and are taking on active roles in managing patients alongside ...

Viral pathogens are increasingly recognized in up to 26% of adult CAP hospitalizations, with influenza and RSV historically ...

Brianne Porter, PharmD, MS, explores how pharmacists can deliver care to a population of women experiencing life-altering symptoms of urinary incontinence.

Similarly, a large cross-sectional study in China evaluating individuals who recovered from COVID-19 found that 42.2% exhibited hesitancy toward subsequent doses, with higher levels of pandemic ...

Pharmacy benefit manager (PBM) reform is gaining momentum nationwide, but experts caution that pharmacies, a cornerstone of ...

Four approved PrEP options now span daily pills and long-acting injections. The faculty review how each agent works and where daily oral PrEP succeeds or falls short in practice. In "The HIV PrEP ...

Long-acting cabotegravir and lenacapavir both deliver near-complete protection. The faculty compare dosing schedules, drug interactions, and injection site reactions, and share techniques that make ...

Approval was given to GSK, making its product the first antisense oligonucleotide established for the treatment of chronic hepatitis B. The FDA approved GSK’s bepirovirsen (Hibsago) injection for the ...

Therapy is aimed at decreasing pathogenic IgA production and immune complex formation as well as managing the effects of ...